Latest news
SK Biopharmaceuticals Establishes Dedicated IP Defense Unit for Xcopri, Bracing for Generic and New Drug Competition - finance.biggo.comfinance.biggo.com · Thu, 06 Aug 2026 07:06:00 GMTSK Biopharmaceuticals Posts Record Q2 Operating Profit of ₩97.1 Billion on Surging US Xcopri Sales - finance.biggo.comfinance.biggo.com · Wed, 05 Aug 2026 02:27:00 GMT